DESCRIPTION:


fiteBac® K18/MMA


10% K18 formulated in liquid MMA

USE:


Liquid MMA component for 2-part acrylate system

TARGET AUDIENCE:


Dental Laboratories

DEVELOPMENT STATUS:


Cleared for use in dental acrylics


PLANNED COMMERCIAL INTRODUCTION:


Q1/2019


BENEFITS:


Manufacture of dentures and retainers with long term antimicrobial resistance to biofilm formation.


DESCRIPTION:


fiteBac® Cavity Cleanser


2% K21 in a solvent base formulation

USE:


Preparation of tooth prior to placement of dental restoration

TARGET AUDIENCE:


Dental Offices

DEVELOPMENT STATUS:


510(k) Submission

Q1/2018

PLANNED COMMERCIAL INTRODUCTION:


Q1/2019

BENEFITS:


Reduced sensitivity and microbiological presence at prepared dentin layer. Stable hybrid layer at dentin-restoration interface.


DESCRIPTION:


fiteBac® OrthoBond


5% K18 in a temporary orthodontic dental adhesive

USE:


Temporarily placement of orthodontic appliances

TARGET AUDIENCE:


Dental Offices

DEVELOPMENT STATUS:


510(k) Submission

Q2/2018

PLANNED COMMERCIAL INTRODUCTION:


Q1/2019

BENEFITS:


Resistance to biofilm formation around and under orthodontic brackets. Reduce risk of surface damage to surface enamel of teeth. Improved cosmetic outcomes.


DESCRIPTION:


fiteBac® Bond


5% K18 in a permanent acrylic based dental adhesive


USE:


Permanent placement of dental appliances and restorations

TARGET AUDIENCE:


Dental Offices

DEVELOPMENT STATUS:


510(k) submission

Q2/2018

PLANNED COMMERCIAL INTRODUCTION:


Q1/2019

BENEFITS:


Resistance to biofilm formation, loss of adhesion and decay under permanent dental restorations.